256 related articles for article (PubMed ID: 19609949)
21. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
[TBL] [Abstract][Full Text] [Related]
22. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
[TBL] [Abstract][Full Text] [Related]
23. JAM3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervix.
Yin A; Zhang Q; Kong X; Jia L; Yang Z; Meng L; Li L; Wang X; Qiao Y; Lu N; Yang Q; Shen K; Kong B
Oncotarget; 2015 Dec; 6(42):44373-87. PubMed ID: 26517242
[TBL] [Abstract][Full Text] [Related]
24. Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape.
Snellenberg S; De Strooper LM; Hesselink AT; Meijer CJ; Snijders PJ; Heideman DA; Steenbergen RD
BMC Cancer; 2012 Nov; 12():551. PubMed ID: 23176198
[TBL] [Abstract][Full Text] [Related]
25. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
[TBL] [Abstract][Full Text] [Related]
26. Genotype distribution of human papillomavirus in women with abnormal cervical cytology in an esophageal carcinoma high incidence area of China.
Mai RQ; Huang B; Shen L; Zhang GH; Hong LL; Cai YM
Asian Pac J Cancer Prev; 2014; 15(12):4945-50. PubMed ID: 24998569
[TBL] [Abstract][Full Text] [Related]
27. [Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].
Guo YL; You K; Geng L; Zhang XW; Shen XY; Yao YJ; Fan XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):480-2. PubMed ID: 17068618
[TBL] [Abstract][Full Text] [Related]
28. PAX1 methylation as a potential biomarker for cervical cancer screening.
Kan YY; Liou YL; Wang HJ; Chen CY; Sung LC; Chang CF; Liao CI
Int J Gynecol Cancer; 2014 Jun; 24(5):928-34. PubMed ID: 24844223
[TBL] [Abstract][Full Text] [Related]
29. Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.
Fackler MJ; Pleas M; Li Y; Soni A; Xing D; Cope L; Ali S; Van Le Q; Van Nguyen C; Pham HT; Duong LM; Vanden Berg E; Wadee R; Michelow P; Chen WC; Joffe M; Fjeldbo CS; Lyng H; Sukumar S
Clin Epigenetics; 2024 Apr; 16(1):56. PubMed ID: 38643219
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
van Leeuwen RW; Oštrbenk A; Poljak M; van der Zee AGJ; Schuuring E; Wisman GBA
Int J Cancer; 2019 Feb; 144(4):746-754. PubMed ID: 30259973
[TBL] [Abstract][Full Text] [Related]
31. Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier.
Ivanov MK; Titov SE; Glushkov SA; Dzyubenko VV; Malek AV; Arkhangelskaya PA; Samsonov RB; Mikhetko AA; Bakhidze EV; Berlev IV; Kolesnikov NN
Oncol Rep; 2018 Mar; 39(3):1099-1111. PubMed ID: 29328473
[TBL] [Abstract][Full Text] [Related]
32. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
[TBL] [Abstract][Full Text] [Related]
33. Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology.
Lee M; Chang MY; Shin HY; Shin E; Hong SW; Kim KM; Chay DB; Cho H; Kim JH
Medicine (Baltimore); 2016 Jan; 95(3):e2425. PubMed ID: 26817873
[TBL] [Abstract][Full Text] [Related]
34. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States.
Liao SY; Rodgers WH; Kauderer J; Bonfiglio TA; Walker JL; Darcy KM; Carter R; Hatae M; Levine L; Spirtos NM; Stanbridge EJ
Int J Cancer; 2009 Nov; 125(10):2434-40. PubMed ID: 19670419
[TBL] [Abstract][Full Text] [Related]
35. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
37. Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests.
Kahn SL; Ronnett BM; Gravitt PE; Gustafson KS
Cancer; 2008 Feb; 114(1):57-64. PubMed ID: 18181097
[TBL] [Abstract][Full Text] [Related]
38. Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.
Verhoef VM; van Kemenade FJ; Rozendaal L; Heideman DA; Bosgraaf RP; Hesselink AT; Melchers WJ; Massuger LF; Bekkers RL; Steenbergen RD; Berkhof J; Snijders PJ; Meijer CJ
Gynecol Oncol; 2015 Apr; 137(1):55-9. PubMed ID: 25667975
[TBL] [Abstract][Full Text] [Related]
39. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
[TBL] [Abstract][Full Text] [Related]
40. Have we resolved how to triage equivocal cervical cytology?
Solomon D; Schiffman M
J Natl Cancer Inst; 2004 Feb; 96(4):250-1. PubMed ID: 14970266
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
